Mast cells-derived exosomes worsen the development of experimental cerebral malaria

Acta Tropica ◽  
2021 ◽  
Vol 224 ◽  
pp. 106145
Author(s):  
Kunhua Huang ◽  
Li Huang ◽  
Xin Zhang ◽  
Min Zhang ◽  
Qianru Wang ◽  
...  
Keyword(s):  
Mast Cells ◽  
Cerebral Malaria ◽  
Experimental Cerebral Malaria

scholarly journals Mast Cells-derived Exosomes Promote the Development of Experimental Cerebral Malaria

2020 ◽  
Author(s):  
Kunhua Huang ◽  
Xin Zhang ◽  
Li Huang ◽  
Hang Lin ◽  
Ziyi Yu ◽  
...  
Keyword(s):  
Mast Cells ◽  
Cerebral Malaria ◽  
Ex Vivo ◽  
Critical Role ◽  
High Morbidity ◽  
Soluble Antigen ◽  
Mrna Levels ◽  
Experimental Cerebral Malaria

Abstract Background: Cerebral malaria (CM) is a severe neurological manifestation caused by Plasmodium infection, with high morbidity and mortality rate, and long-term cognitive impairments in survivors. Exosomes are cell-derived nano-vesicles secreted by virtually all types of cells and serve as mediators of intercellular communication. Studies have demonstrated that mast cells (MCs) play a critical role in mediating malaria severity, however, the potential functions and pathological mechanisms of MCs-derived exosome (MCs-Exo) impacting on CM pathogenesis remain largely unknown. Methods: Herein, we utilized an experimental CM (ECM) murine model (C57BL/6 mice infected with P. berghei ANKA), and then intravenously (i.v.) injected MCs-Exo into ECM mice to investigate the effect of MCs-Exo on ECM pathogenies. We also used an in vitro model by investigating the pathogenesis development of brain microvascular endothelial cells line (bEnd.3 cells) upon MCs-Exo treatment after P. berghei ANKA blood-stage soluble antigen (PbAg) stimulation. Results: MCs-Exo were successfully isolated from culture supernatants of mouse MCs line (P815 cells) stimulated with PbAg, characterized by spherical vesicles with the diameter of 30–150 nm, expressing of typical exosomal markers, including CD9, CD81, and CD63. In vivo and ex vivo tracking showed that DiR-labeled MCs-Exo were taken up by liver and brain tissues after 6 h of i.v. injection. Compared with naive mice, ECM mice exhibited higher numbers of MCs and higher levels of MCs degranulation in various tissues (e.g., brain, cervical lymph node, and skin). The present of MCs-Exo dramatically shortened survival time, elevated incident of ECM, exacerbated liver and brain histopathological damage, promoted Th1 cytokine response, and aggravated brain vascular endothelial activation and blood brain barrier breakdown in ECM mice. Interestingly, compared with bEnd.3 cells stimulated with PbAg, the treatment of MCs-Exo led to decrease of cells viability, increase the mRNA levels of Ang-2, CCL2, CXCL1, and CXCL9, and decrease the mRNA levels of Ang-1, ZO-1, and Claudin-5. Conclusions: Thus, our data suggest that MCs-Exo could promote pathogenesis of ECM in mice.

CCR5 deficiency decreases susceptibility to experimental cerebral malaria

Blood ◽  
2003 ◽  
Vol 101 (11) ◽  
pp. 4253-4259 ◽  
Author(s):  
Elodie Belnoue ◽  
Michèle Kayibanda ◽  
Jean-Christophe Deschemin ◽  
Mireille Viguier ◽  
Matthias Mack ◽  
...  
Keyword(s):  
T Cells ◽  
Cerebral Malaria ◽  
Cd8 T Cells ◽  
Cytokine Production ◽  
Wild Type ◽  
Experimental Cerebral Malaria ◽  
Pathologic Features ◽  
Th1 Cytokine ◽  
The Brain ◽  
Deficient Mice

Abstract Infection of susceptible mouse strains with Plasmodium berghei ANKA (PbA) is a valuable experimental model of cerebral malaria (CM). Two major pathologic features of CM are the intravascular sequestration of infected erythrocytes and leukocytes inside brain microvessels. We have recently shown that only the CD8+ T-cell subset of these brain-sequestered leukocytes is critical for progression to CM. Chemokine receptor–5 (CCR5) is an important regulator of leukocyte trafficking in the brain in response to fungal and viral infection. Therefore, we investigated whether CCR5 plays a role in the pathogenesis of experimental CM. Approximately 70% to 85% of wild-type and CCR5+/- mice infected with PbA developed CM, whereas only about 20% of PbA-infected CCR5-deficient mice exhibited the characteristic neurologic signs of CM. The brains of wild-type mice with CM showed significant increases in CCR5+ leukocytes, particularly CCR5+ CD8+ T cells, as well as increases in T-helper 1 (Th1) cytokine production. The few PbA-infected CCR5-deficient mice that developed CM exhibited a similar increase in CD8+ T cells. Significant leukocyte accumulation in the brain and Th1 cytokine production did not occur in PbA-infected CCR5-deficient mice that did not develop CM. Moreover, experiments using bone marrow (BM)–chimeric mice showed that a reduced but significant proportion of deficient mice grafted with CCR5+ BM develop CM, indicating that CCR5 expression on a radiation-resistant brain cell population is necessary for CM to occur. Taken together, these results suggest that CCR5 is an important factor in the development of experimental CM.

A Neuroprotective Effect of the Glutamate Receptor Antagonist MK801 on Long-Term Cognitive and Behavioral Outcomes Secondary to Experimental Cerebral Malaria

2016 ◽  
Vol 54 (9) ◽  
pp. 7063-7082 ◽  
Author(s):  
Aline Silva de Miranda ◽  
Fátima Brant ◽  
Luciene Bruno Vieira ◽  
Natália Pessoa Rocha ◽  
Érica Leandro Marciano Vieira ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Cerebral Malaria ◽  
Glutamate Receptor ◽  
Neuroprotective Effect ◽  
Behavioral Outcomes ◽  
Glutamate Receptor Antagonist ◽  
Experimental Cerebral Malaria

scholarly journals THEMIS Is Required for Pathogenesis of Cerebral Malaria and Protection against Pulmonary Tuberculosis

2014 ◽  
Vol 83 (2) ◽  
pp. 759-768 ◽  
Author(s):  
Sabrina Torre ◽  
Sebastien P. Faucher ◽  
Nassima Fodil ◽  
Silayuv E. Bongfen ◽  
Joanne Berghout ◽  
...  
Keyword(s):  
Pulmonary Tuberculosis ◽  
Cerebral Malaria ◽  
Functional Coupling ◽  
Experimental Cerebral Malaria ◽  
Content Type ◽  
Proinflammatory Responses ◽  
Inflammatory Bowel ◽  
Blood Brain Barrier Integrity

We identify anN-ethyl-N-nitrosourea (ENU)-induced I23N mutation in the THEMIS protein that causes protection against experimental cerebral malaria (ECM) caused by infection withPlasmodium bergheiANKA.ThemisI23Nhomozygous mice show reduced CD4+and CD8+T lymphocyte numbers. ECM resistance inP. bergheiANKA-infectedThemisI23Nmice is associated with decreased cerebral cellular infiltration, retention of blood-brain barrier integrity, and reduced proinflammatory cytokine production. THEMISI23Nprotein expression is absent from mutant mice, concurrent with the decreased THEMISI23Nstability observedin vitro. Biochemical studiesin vitroand functional complementationin vivoinThemisI23N/+:Lck−/+doubly heterozygous mice demonstrate that functional coupling of THEMIS to LCK tyrosine kinase is required for ECM pathogenesis. Damping of proinflammatory responses inThemisI23Nmice causes susceptibility to pulmonary tuberculosis. Thus, THEMIS is required for the development and ultimately the function of proinflammatory T cells.ThemisI23Nmice can be used to study the newly discovered association ofTHEMIS(6p22.33) with inflammatory bowel disease and multiple sclerosis.

scholarly journals Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model

2013 ◽  
Vol 12 (1) ◽  
pp. 302 ◽  
Author(s):  
Jérôme Dormoi ◽  
Sébastien Briolant ◽  
Aurélie Pascual ◽  
Camille Desgrouas ◽  
Christelle Travaillé ◽  
...  
Keyword(s):  
Cerebral Malaria ◽  
Murine Model ◽  
Experimental Cerebral Malaria

Evidence for the contribution of adult neurogenesis and hippocampal cell death in experimental cerebral malaria cognitive outcome

Neuroscience ◽  
2015 ◽  
Vol 284 ◽  
pp. 920-933 ◽  
Author(s):  
A.S. de Miranda ◽  
F. Brant ◽  
A.C. Campos ◽  
L.B. Vieira ◽  
N.P. Rocha ◽  
...  
Keyword(s):  
Cell Death ◽  
Cerebral Malaria ◽  
Adult Neurogenesis ◽  
Cognitive Outcome ◽  
Experimental Cerebral Malaria ◽  
Hippocampal Cell

scholarly journals Gamma Interferon Mediates Experimental Cerebral Malaria by Signaling within Both the Hematopoietic and Nonhematopoietic Compartments

2017 ◽  
Vol 85 (11) ◽  
Author(s):  
Ana Villegas-Mendez ◽  
Patrick Strangward ◽  
Tovah N. Shaw ◽  
Ivana Rajkovic ◽  
Vinko Tosevski ◽  
...  
Keyword(s):  
Endothelial Cells ◽  
Cerebral Malaria ◽  
Myeloid Cell ◽  
Gamma Interferon ◽  
Cell Populations ◽  
Experimental Cerebral Malaria ◽  
Cerebral Pathology ◽  
Multiple Cell ◽  
Ifn Γ

ABSTRACT Experimental cerebral malaria (ECM) is a gamma interferon (IFN-γ)-dependent syndrome. However, whether IFN-γ promotes ECM through direct and synergistic targeting of multiple cell populations or by acting primarily on a specific responsive cell type is currently unknown. Here, using a panel of cell- and compartment-specific IFN-γ receptor 2 (IFN-γR2)-deficient mice, we show that IFN-γ causes ECM by signaling within both the hematopoietic and nonhematopoietic compartments. Mechanistically, hematopoietic and nonhematopoietic compartment-specific IFN-γR signaling exerts additive effects in orchestrating intracerebral inflammation, leading to the development of ECM. Surprisingly, mice with specific deletion of IFN-γR2 expression on myeloid cells, T cells, or neurons were completely susceptible to terminal ECM. Utilizing a reductionist in vitro system, we show that synergistic IFN-γ and tumor necrosis factor (TNF) stimulation promotes strong activation of brain blood vessel endothelial cells. Combined, our data show that within the hematopoietic compartment, IFN-γ causes ECM by acting redundantly or by targeting non-T cell or non-myeloid cell populations. Within the nonhematopoietic compartment, brain endothelial cells, but not neurons, may be the major target of IFN-γ leading to ECM development. Collectively, our data provide information on how IFN-γ mediates the development of cerebral pathology during malaria infection.

Sign in / Sign up

Export Citation Format

Share Document